Effect of parental age on treatment response in adolescents with schizophrenia

Schizophrenia Research

Volumn 151, Issue 1-3, 2013, Pages 185-190

  Opler, Mark ^a   Malaspina, Dolores ^a   Gopal, Srihari ^b   Nuamah, Isaac ^b   Savitz, Adam J ^b   Singh, Jaskaran ^b   Hough, David ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adolescents; Heterogeneity; Paternal age; Placebo; Schizophrenia; Treatment response

Indexed keywords

PALIPERIDONE; PLACEBO;

ADOLESCENCE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MIDDLE AGED; ONSET AGE; PARENTAL AGE; PATERNAL AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCORING SYSTEM; YOUNG ADULT;

ADOLESCENTS; HETEROGENEITY; PATERNAL AGE; PLACEBO; SCHIZOPHRENIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATERNAL AGE; PYRIMIDINES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84889085982     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.10.001     Document Type: Article

References (32)

1. Buizer-Voskamp J.E., Laan W., Staal W.G., Hennekam E.A., Aukes M.F., Termorshuizen F., et al. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophr. Res. 2011, 129(2-3):128-132.
2. Byrne M., Agerbo E., Ewald H., Eaton W.W., Mortensen P.B. Parental age and risk of schizophrenia: a case-control study. Arch. Gen. Psychiatry 2003, 60(7):673-678.
3. Ek M., Wicks S., Magnusson C., Dalman C. Adoptive paternal age and risk of psychosis in adoptees: a register based cohort study. PLoS One 2012, 7(10):e47334. (Epub ahead of print, 10 Oct 2012). 10.1371/journal.pone.0047334.
4. Goriely A., Wilkie A.O. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am. J. Hum. Genet. 2012, 90(2):175-200.
5. Goriely A., McGrath J.J., Hultman C.M., Wilkie A.O., Malaspina D. Selfish spermatogonial selection: a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders. Am. J. Psychiatry 2013, 170(6):599-608. (Review, PubMed PMID:23639989). 10.1176/appi.ajp.2013.12101352.
6. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Consortium on the Genetics of Schizophrenia (COGS), Nimgaonkar V.L., Go R.C., Savage R.M., Swerdlow N.R., Gur R.E., Braff D.L., King M.C., McClellan J.M. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154(3):518-529. PAARTNERS StudyGroup. 10.1016/j.cell.2013.06.049. PubMed PMID: 23911319.
7. Hafner H., an der Heiden W. Epidemiology of schizophrenia. Can. J. Psychiatry 1997, 42(2):139-151.
8. Hafner H., Riecher A., Maurer K., Loffler W., Munk-Jorgensen P., Stromgren E. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol. Med. 1989, 19(4):903-918.
9. Hehir-Kwa J.Y., Rodriguez-Santiago B., Vissers L.E., de Leeuw N., Pfundt R., Buitelaar J.K., et al. De novo copy number variants associated with intellectual disability have a paternal origin and age bias. J. Med. Genet. 2011, 48(11):776-778.
10. Hubert A., Szoke A., Leboyer M., Schurhoff F. Influence of paternal age in schizophrenia. Encéphale 2011, 37(3):199-206.
11. Hultman C.M., Sandin S., Levine S.Z., Lichtenstein P., Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol. Psychiatry 2011, 16(12):1203-1212.
12. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36(7):980-988.
13. Kong A., Frigge M.L., Masson G., Besenbacher S., Sulem P., Magnusson G., et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012, 488(7412):471-475.
14. Lee H., Malaspina D., Ahn H., Perrin M., Opler M.G., Kleinhaus K., et al. Paternal age related schizophrenia (PARS): latent subgroups detected by k-means clustering analysis. Schizophr. Res. 2011, 128(1-3):143-149.
15. Lee S., Son H., Lee J., Lee Y.R., Lee Y.W. A putative ABC transporter gene, ZRA1, is required for zearalenone production in Gibberella zeae. Curr. Genet. 2011, 57(5):343-351.
16. Lundstrom S., Haworth C.M., Carlstrom E., Gillberg C., Mill J., Rastam M., et al. Trajectories leading to autism spectrum disorders are affected by paternal age: findings from two nationally representative twin studies. J. Child Psychol. Psychiatry 2010, 51(7):850-856.
17. Malaspina D., Goetz R.R., Yale S., Berman A., Friedman J.H., Tremeau F., et al. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome. Am. J. Psychiatry 2000, 157(6):994-1003.
18. Malaspina D., Harlap S., Fennig S., Heiman D., Nahon D., Feldman D., et al. Advancing paternal age and the risk of schizophrenia. Arch. Gen. Psychiatry 2001, 58(4):361-367.
19. Malaspina D., Corcoran C., Fahim C., Berman A., Harkavy-Friedman J., Yale S., et al. Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am. J. Med. Genet. 2002, 114(3):299-303.
20. Malaspina D., Harkavy-Friedman J., Corcoran C., Mujica-Parodi L., Printz D., Gorman J.M., et al. Resting neural activity distinguishes subgroups of schizophrenia patients. Biol. Psychiatry 2004, 56(12):931-937.
21. Malaspina D., Reichenberg A., Weiser M., Fennig S., Davidson M., Harlap S., et al. Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr. Genet. 2005, 15(2):117-125.
22. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J. Clin. Psychiatry 1997, 58(12):538-546.
23. Matheson S.L., Shepherd A.M., Laurens K.R., Carr V.J. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr. Res. 2011, 133(1-3):133-142.
24. Mattai A.K., Hill J.L., Lenroot R.K. Treatment of early-onset schizophrenia. Curr. Opin. Psychiatry 2010, 23(4):304-310.
25. Miller B., Messias E., Miettunen J., Alaraisanen A., Jarvelin M.R., Koponen H., et al. Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophr. Bull. 2011, 37(5):1039-1047.
26. Rosenfield P.J., Kleinhaus K., Opler M., Perrin M., Learned N., Goetz R., et al. Later paternal age and sex differences in schizophrenia symptoms. Schizophr. Res. 2010, 116(2-3):191-195.
27. Sandin S., Hultman C.M., Kolevzon A., Gross R., MacCabe J.H., Reichenberg A. Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51(5):477-486. (e471).
28. Singh J., Robb A., Vijapurkar U., Nuamah I., Hough D. A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents. Biol. Psychiatry 2011, 70(12):1179-1187.
29. Szeszko P.R., Narr K.L., Phillips O.R., McCormack J., Sevy S., Gunduz-Bruce H., et al. Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. Schizophr. Bull. 2010, 38(3):569-578. 10.1093/schbul/sbq126. Epub 2010 Nov 17.
30. Torrey E.F., Buka S., Cannon T.D., Goldstein J.M., Seidman L.J., Liu T., et al. Paternal age as a risk factor for schizophrenia: how important is it?. Schizophr. Res. 2009, 114(1-3):1-5.
31. Van den Oord E.J., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszar J., et al. Factor structure and external validity of the PANSS revisited. Schizophr. Res. 2006, 82(2-3):213-223.
32. Wolitzky R., Goudsmit N., Goetz R.R., Printz D., Gil R., Harkavy-Friedman J., et al. Etiological heterogeneity and intelligence test scores in patients with schizophrenia. J. Clin. Exp. Neuropsychol. 2006, 28(2):167-177.